Olshan Frome Wolosky LLP represented Summit Therapeutics in the offering.Summit Therapeutics Inc. (NASDAQ: SMMT) executed its rights offering of up to 14,312,977 shares of its common…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
